Monte Rosa TherapeuticsGLUE
GLUE
$6.48
3.68%
Market Cap: $398M
0
Funds holding %
of 6,728 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
320% more call options, than puts
Call options by funds: $374K | Put options by funds: $89K
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
9% more funds holding
Funds holding: 68 [Q1] → 74 (+6) [Q2]
4.7% less ownership
Funds ownership: 79.66% [Q1] → 74.96% (-4.7%) [Q2]
39% less capital invested
Capital invested by funds: $282M [Q1] → $171M (-$110M) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$11
70%
upside
Avg. target
$14.67
126%
upside
High target
$17
162%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Wedbush Robert Driscoll 56% 1-year accuracy 38 / 68 met price target | 70%upside $11 | Outperform Reiterated | 12 Sept 2024 |
Wells Fargo Derek Archila 69% 1-year accuracy 20 / 29 met price target | 162%upside $17 | Overweight Maintained | 12 Aug 2024 |
Piper Sandler Edward Tenthoff 46% 1-year accuracy 18 / 39 met price target | 147%upside $16 | Overweight Reiterated | 28 Jun 2024 |